Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
Jinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112538-112538
Open Access | Times Cited: 24

Showing 24 citing articles:

H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours
Diego Dibitetto, Martin Liptay, Francesca Vivalda, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
BRCAness, DNA gaps, and gain and loss of PARP inhibitor–induced synthetic lethality
Xin Li, Lee Zou
Journal of Clinical Investigation (2024) Vol. 134, Iss. 14
Open Access | Times Cited: 13
PARPi, BRCA, and gaps: controversies and future research
Diego Dibitetto, Carmen A. Widmer, Sven Rottenberg
Trends in cancer (2024) Vol. 10, Iss. 9, pp. 857-869
Open Access | Times Cited: 10
PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair
Christina Andronikou, Kamila Burdová, Diego Dibitetto, et al.
The EMBO Journal (2024) Vol. 43, Iss. 6, pp. 1015-1042
Open Access | Times Cited: 9
Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: implications for the involvement of pirin
Bardees M. Foda, Amanda F. Baker, Łukasz Joachimiak, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
The power and the promise of synthetic lethality for clinical application in cancer treatment
Qianwen Liu, Zhiwen Yang, Qing-Hai Tang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116288-116288
Open Access | Times Cited: 6
C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer
Xi Li, Alfonso Poire, Kang Jin Jeong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Positioning Loss of PARP1 Activity as the Central Toxic Event in BRCA-Deficient Cancer
Nathan J. MacGilvary, Sharon B. Cantor
DNA repair (2024) Vol. 144, pp. 103775-103775
Open Access | Times Cited: 5
53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer
Yajie Sun, Jeffrey Patterson-Fortin, Sen Han, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Strategies for the prevention or reversal of PARP inhibitor resistance
Zahi Mitri, Shaun Goodyear, Gordon B. Mills
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 10, pp. 959-975
Open Access | Times Cited: 4
Targeting FEN1/EXO1 to enhance efficacy of PARP inhibition in triple-negative breast cancer
Mallory I. Frederick, Elicia Fyle, Anna Clouvel, et al.
Translational Oncology (2025) Vol. 54, pp. 102337-102337
Closed Access
SETD1A-dependent EME1 transcription drives PARPi sensitivity in HR deficient tumour cells
Ellie Sweatman, Rachel Bayley, Richad Selemane, et al.
British Journal of Cancer (2025)
Open Access
Synthetic lethality in cancer: a protocol for scoping review of gene interactions from synthetic lethal screens and functional studies
Ritika Chauhan, Rama Rao Damerla, Vijay Shree Dhyani
Systematic Reviews (2025) Vol. 14, Iss. 1
Open Access
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Daniel H. Jacobson, Pan Shi, Jasmin Fisher, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer
Yifan Tai, Angela Chow, Seo-Young Han, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 8, pp. 1957-1980
Open Access | Times Cited: 3
FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer
Yu-Zhou Huang, Ming‐Yi Sang, Pei-Wen Xi, et al.
Cancer Research (2024) Vol. 84, Iss. 20, pp. 3447-3463
Closed Access | Times Cited: 2
Leveraging PARP-1/2 to Target Distant Metastasis
Mallory I. Frederick, Djihane Abdesselam, Anna Clouvel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9032-9032
Open Access | Times Cited: 2
DNA repair, gap suppression, or fork protection: BRCA2 needs a break!
Diego Dibitetto, Sven Rottenberg
Molecular Cell (2024) Vol. 84, Iss. 3, pp. 409-410
Open Access | Times Cited: 1
Persisting cancer cells are different from bacterial persisters
Morgane Decollogny, Sven Rottenberg
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 393-406
Open Access | Times Cited: 1
Multi-scale characterisation of homologous recombination deficiency in breast cancer
Daniel H. Jacobson, Pan Shi, Jasmin Fisher, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
SETD1A-dependent EME1 transcription drives PARPi sensitivity in HR deficient tumour cells
Ellie Sweatman, Rachel Bayley, Richad Selemane, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Molecular mechanism of PARP inhibitor resistance
Yi Huang, Simin Chen, Nan Yao, et al.
Oncoscience (2024) Vol. 11, pp. 69-91
Open Access
Mechanistic insights into Rho/MRTF inhibition-induced apoptotic events and prevention of drug resistance in melanoma: Implications for the involvement of pirin
Bardees M. Foda, Amanda F. Baker, Łukasz Joachimiak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours
Diego Dibitetto, Martin Liptay, Francesca Vivalda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top